CalyxoPRIVATE · FOUNDED 2016
EgenesisPRIVATE · FOUNDED 2015Each bar is the last disclosed mark — $684.6M for Calyxo (basis undisclosed, Apr 2026) and $350M for Egenesis (post-money, Feb 2021).


CalyxoPRIVATEHealth · US · 2016
EgenesisPRIVATEHealth · US · 2015
The $684.6M tells you…
The $350M tells you…At least one valuation basis is undisclosed, so the two numbers stay side by side, each with its own chip, and no ratio is scored. Both are private: there is no public quote and no Canborsa market on either name.
Calyxo's sector is Medical Devices; Egenesis' sector is Biotechnology / Healthcare.
Calyxo is valued at $684.6M, and Egenesis at $350M.
Calyxo raised $40M through its Series F round in April 2026, while Egenesis raised $191M through its Series D round in June 2024.
Calyxo's lead investors include Ally Bridge Group and Janus Henderson Investors, and Egenesis' include Lux Capital.